Our Opinion

Ziopharm is on the Cruelty Free Investing list for exploiting animals because the company does animal testing for some of their medical products and therapies.

Company Description

Ziopharm Oncology is a biotechnology company employing novel gene expression, control and cell technologies to deliver cell-based therapies for the treatment of cancer and graft-versus-host-disease (GvHD), a type of auto-immune disease. The company’s synthetic immuno-oncology programs, in collaboration with Intrexon Corporation  and the MD Anderson Cancer Center, include chimeric antigen receptor-modified T cells (CAR-T), T-cell receptor (TCR)-modified T cells, and other adoptive cell-based approaches that use non-viral and viral gene transfer methods for scalability.